Taken together, our findings highlight the significance of DDX17 in the clinical outcome of CRC patients and delineate an important molecular mechanism by which DDX17 contributes to CRC metastasis through manipulation of the miR-149-3p/CYBRD1 axis. Here, CYBRD1 is linked to colorectal carcinoma.